Tumor necrosis factor gene and microsatellite polymorphism in chronic inflammatory bowel diseases.

被引:0
|
作者
Heresbach, D
Ababou, A
Bourienne, A
Alizadeh, M
Quelvennec, E
Pagenault, M
Dabadie, A
HeresbachLeBerre, N
Campion, JP
Launois, B
Gosselin, M
Genetet, B
Bretagne, JF
Semana, G
机构
[1] CHRU PONTCHAILLOU,SERV HEPATOGASTROENTEROL,RENNES,FRANCE
[2] CHRU PONTCHAILLOU,SERV PEDIAT,RENNES,FRANCE
[3] CHRU PONTCHAILLOU,CLIN CHIRURG B,RENNES,FRANCE
[4] ETABLISSEMENT TRANSFUS SANGUINE BRETAGNE EST,LAB UNIV IMMUNOL,RENNES,FRANCE
来源
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE | 1997年 / 21卷 / 8-9期
关键词
inflammatory bowel disease; Crohn's disease; microsatellites; tumor necrosis factor;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives. - Multiplex family studies have excluded chromosome 6 as a candidate gene of susceptibility to inflammatory bowel disease. However one recent study suggested that a gene involved in the pathogenesis of Crohn's disease is located on chromosome 6 confering to a microsatellite allelic combination (a2, b1, c2, d4, e1) a strong genetic risk factor in Crohn's disease. The aim of our study was to determine simultaneously the polymorphisms of the TNF microsatellites and of the the genes coding for TNF synthesis in patients with inflammatory bowel disease. Patients and methods. - Sixty patients with ulcerative colitis, 100 patients with Crohn's disease were compared to 64 healthy ethnically matched controls. Five TNF microsatellite loci (a, b, c, d, e) were typed using polymerase chain reaction PCR, and two dimorphisms of TNF alpha and TNF beta (intron 1) were studied by restriction fragment length polymorphism (RFLP). Results. - Allelic frequencies of TNF microsatellites and of TNF alpha and beta genes were similar in Crohn's disease, ulcerative colitis and controls. Five loci microsatellite haplotypes, especially a2 b1 c2 d4 e1 allelic combination, were not more frequent in Crohn's disease (25 %) compared to ulcerative colitis (27 %) or controls (20 %). Subgroups stratification according to clinical characteristics did not modify haplotype frequencies. Analysis of our data taking simultaneously into account the MHC alleles (DRB1*01 or DRB1*04) did not modify our data ; however it suggested that extended haplotype on short arm of chromosome 6 differed between patients and controls. Linkage disequilibrium (Delta = -360.10(-4); P < 0.01) between a2, b1, c2, d4, e1 allelic combination and DRB1*04 allele was observed only in Crohn's disease. Conclusion. - Percentages of patients with Crohn's disease or ulcerative colitis carrying TNF microsatellite or TNF alpha and beta gene haplotypes were similar to those of healthy controls. These data argue against involvement of the TNF locus without exclusion of short arm of chromosome 6 implication in Crohn's disease pathogenesis.
引用
收藏
页码:555 / 561
页数:7
相关论文
共 50 条
  • [1] Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk
    Lynnette R Ferguson
    Claudia Huebner
    Ivonne Petermann
    Richard B Gearry
    Murray L Barclay
    Pieter Demmers
    Alan McCulloch
    Dug Yeo Han
    World Journal of Gastroenterology, 2008, (29) : 4652 - 4661
  • [2] Single nucleotide polymorphism in the tumor necrosis factor-alpha gene affects inflammatory bowel diseases risk
    Ferguson, Lynnette R.
    Huebner, Claudia
    Petermann, Ivonne
    Gearry, Richard B.
    Barclay, Murray L.
    Demmers, Pieter
    McCulloch, Alan
    Han, Dug Yeo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (29) : 4652 - 4661
  • [3] Association of the hSRBC polymorphism with inflammatory bowel diseases.
    Kim, H.
    Hwangbo, Y.
    Shim, J.
    Jang, J.
    Dong, S.
    Kim, B.
    Chang, Y.
    Chang, R.
    INFLAMMATORY BOWEL DISEASES, 2011, 17 : S23 - S23
  • [4] Tumor necrosis factor gene polymorphism in chronic sinusitis
    Takeuchi, K
    Majima, Y
    Sakakura, Y
    LARYNGOSCOPE, 2000, 110 (10): : 1711 - 1714
  • [5] Effect of heparin on interleukin-6 and tumor necrosis factor alpha serum levels in inflammatory bowel diseases.
    Brazier, F
    Yzet, T
    Dessaint, C
    Duchmann, JC
    Prin, L
    Dupas, JL
    GASTROENTEROLOGY, 1996, 110 (04) : A871 - A871
  • [6] TUMOR NECROSIS FACTOR IMPACTS INFLIXIMAB CLEARANCE IN INFLAMMATORY BOWEL DISEASES
    Young, Leslie
    Dervieux, Thierry
    Panetta, John C.
    Mould, Diane R.
    Eser, Alexander
    Reinisch, Walter
    GASTROENTEROLOGY, 2021, 160 (06) : S706 - S706
  • [7] Inflammatory bowel diseases.
    Lee, BF
    Chiu, NT
    Wu, DC
    Jan, CM
    Tsai, KB
    Liu, GC
    Yu, HS
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1095 - 1095
  • [8] HLA class II antigens and tumor necrosis factor (TNF) gene polymorphism in patients with autoimmune cholestatic liver diseases.
    Bittencourt, PL
    Palacios, SA
    Cancado, EL
    Porta, G
    Farias, AQ
    Carrilho, FJ
    Marin, ML
    Laudanna, AA
    Kalil, J
    Goldberg, AC
    HEPATOLOGY, 1999, 30 (04) : 562A - 562A
  • [9] Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases
    Olesen, Caroline Meyer
    Coskun, Mehmet
    Peyrin-Biroulet, Laurent
    Nielsen, Ole Haagen
    PHARMACOLOGY & THERAPEUTICS, 2016, 159 : 110 - 119
  • [10] Anti-tumor necrosis factor therapy for pediatric inflammatory bowel diseases
    Bujanover, Yoram
    Weiss, Batia
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (8-9): : 634 - 639